Anxiety News and Research

Latest Anxiety News and Research

Neurocrine Biosciences announces GSK561679 antagonist's efficacy in major depressive disorder

Neurocrine Biosciences, Inc. today announced top-line efficacy and safety results from a Phase II clinical trial utilizing Corticotropin Releasing Factor (CRF1) receptor antagonist GSK561679 in patients currently experiencing a major depressive episode.

15 Sep 2010

Heart patients with Type D personality at higher risk of future cardiovascular problems

Heart patients with the "distressed" (Type D) personality profile may face a higher risk of future cardiovascular problems, according to a summary article published in the American Heart Association journal Circulation: Cardiovascular Quality and Outcomes.

15 Sep 2010

Researchers develop new blood test to predict prostate cancer risk

A blood test at the age of 60 can accurately predict the risk that a man will die from prostate cancer within the next 25 years, according to researchers at Memorial Sloan-Kettering Cancer Center, in New York, and Lund University, in Sweden. The findings, published today online in the British Medical Journal, could have important implications for determining which men should be screened after the age of 60 and which may not benefit substantially from continued prostate cancer screening.

15 Sep 2010

Scientists discover study of calcium deposits helps effective breast cancer diagnosis

SCIENTISTS have discovered for the first time that studying calcium deposits in the breast, often detected through screening, could help doctors diagnose breast cancer more effectively.The study, published in the British Journal of Cancer today (Wednesday), examined the relationship between the composition of these deposits found in breast tissue and the malignancy of a tumour.

15 Sep 2010

Gilead Sciences announces Quad regimen Phase II clinical trial results for HIV infection treatment

Gilead Sciences, Inc. today announced Phase II clinical trial results showing that its investigational fixed-dose, single-tablet "Quad" regimen of elvitegravir, cobicistat and Truvada (emtricitabine and tenofovir disoproxil fumarate) for the treatment of HIV infection maintained a high rate of virologic suppression through 48 weeks, exhibiting antiretroviral activity comparable to that of Atripla(efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg).

14 Sep 2010

MSKCC to open new 7,745-square-foot outpatient chemotherapy center in Brooklyn

Memorial Sloan-Kettering Cancer Center (MSKCC) today celebrated a new outpatient chemotherapy center, which is scheduled to open later this month, pending approval from the State Department of Health. The 7,745-square-foot facility, called the Brooklyn Infusion Center, will provide leading-edge chemotherapy services to current MSKCC patients who live in or near Brooklyn — which amounts to more than 15 percent of MSKCC's patients currently being treated in Manhattan.

14 Sep 2010

Depression in children and teens need to be treated early

Depression in children and teenagers can be very debilitating and can have a lifelong impact. Parents who suspect their child, even their youngster, might be depressed should seek help right away rather than simply hope their child will eventually "grow out of it."

14 Sep 2010

Neural inhibition critical in ability to make choices

A new University of Colorado at Boulder study sheds light on the brain mechanisms that allow us to make choices and ultimately could be helpful in improving treatments for the millions of people who suffer from the effects of anxiety disorders.

14 Sep 2010

Lawmakers, Axelrod push and pull on what health reform means to campaigns

Politico: Senior White House adviser David Axelrod said Sunday that he thinks voters will eventually warm to health care reform. He made his comments on NBC's "Meet the Press."

13 Sep 2010

Researchers present study results of psychosocial trauma experienced at 2006 Dawson College shooting

A research team from the McGill University Health Centre (MUHC) and Fernand-Seguin Research Centre of Louis-H. Lafontaine Hospital presented today the results of its three-year study, a world first, into the 2006 Dawson College shooting to the Government of Quebec's Ministry of Public Security.

10 Sep 2010

Research can helps to develop targeted psychological intervention to assist couples cope with PVD

An investigation published in The Journal of Sexual Medicine has found that male partners who express greater support, attention and sympathy to women's chronic vulvovaginal pain may trigger more pain, but also increase sexual satisfaction in female partners.

10 Sep 2010

Candida Force program of detoxification and dietary recommendations effective for weight reduction

Early this month, the cover of First for Women magazine stopped Kathleen Kalaf in her tracks. The magazine featured an article about the connection between systemic Candida, or yeast overgrowth, and fat.

10 Sep 2010

Researchers find minocycline antibiotics effective for fragile X syndrome

One of the antibiotics most commonly prescribed to treat adolescent acne can increase attention spans and communication and decrease anxiety in patients with fragile X syndrome, the most common inherited cause of mental impairment, according to a new survey study that is the first published on parents' reports of their children's responses to treatment with the medication.

9 Sep 2010

Illegal drug usage in older people reduces quality of life: Research

Health and social services are facing a new challenge, as many illicit drug users get older and face chronic health problems and a reduced quality of life. That is one of the key findings of research published in the September issue of the Journal of Advanced Nursing.

9 Sep 2010

Consumption of medications for treatment of insomnia or anxiety increases mortality risk

Taking medications to treat insomnia and anxiety increases mortality risk by 36%, according to a study conducted by Genevi-ve Belleville, a professor at Universit- Laval's School of Psychology. The details of this study are published in the latest edition of the Canadian Journal of Psychiatry.

9 Sep 2010

'Revenge of the Introverts' addresses new research

The work of West Virginia author and psychologist Laurie Helgoe of Charleston is the cover story in the latest issue of the national magazine, Psychology Today.

8 Sep 2010

Health law rollout effects: Delivering 'accountable' care, device tax, nursing mothers

Today's updates on the continuing implementation of the health law include Medicare chief Don Berwick's behind the scenes push for 'accountable care organizations,' tax anxiety in the medical device industry, and the promise of new help for pregnant women.

8 Sep 2010

DTC consumers express concern on personal genetic risk test

One half of people using direct to consumer (DTC) personal genetic risk tests express concerns about testing yet more than 80 percent want to know their risk even for non preventable genetic diseases, according to a study in the September Genetics in Medicine, the official peer reviewed journal of The American College of Medical Genetics (ACMG).

8 Sep 2010

Rexahn submits Phase IIb protocol to FDA for study of Serdaxin for major depressive disorder

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin for the treatment of major depressive disorder (MDD).

7 Sep 2010

Hallucinogen psilocybin safe for administration in patients with advanced-stage cancer and anxiety: Study

A pilot study suggests the hallucinogen psilocybin may be feasible and safe to administer to patients with advanced-stage cancer and anxiety, with promising effects on mood, according to a report published online today that will appear in the January 2011 print issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

7 Sep 2010

Anxiety News and Research

Latest Anxiety News and Research

Neurocrine Biosciences announces GSK561679 antagonist's efficacy in major depressive disorder

Heart patients with Type D personality at higher risk of future cardiovascular problems

Researchers develop new blood test to predict prostate cancer risk

Scientists discover study of calcium deposits helps effective breast cancer diagnosis

Gilead Sciences announces Quad regimen Phase II clinical trial results for HIV infection treatment

MSKCC to open new 7,745-square-foot outpatient chemotherapy center in Brooklyn

Depression in children and teens need to be treated early

Neural inhibition critical in ability to make choices

Lawmakers, Axelrod push and pull on what health reform means to campaigns

Researchers present study results of psychosocial trauma experienced at 2006 Dawson College shooting

Research can helps to develop targeted psychological intervention to assist couples cope with PVD

Candida Force program of detoxification and dietary recommendations effective for weight reduction

Researchers find minocycline antibiotics effective for fragile X syndrome

Illegal drug usage in older people reduces quality of life: Research

Consumption of medications for treatment of insomnia or anxiety increases mortality risk

'Revenge of the Introverts' addresses new research

Health law rollout effects: Delivering 'accountable' care, device tax, nursing mothers

DTC consumers express concern on personal genetic risk test

Rexahn submits Phase IIb protocol to FDA for study of Serdaxin for major depressive disorder

Hallucinogen psilocybin safe for administration in patients with advanced-stage cancer and anxiety: Study

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Anxiety News and Research

Latest Anxiety News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Newsletters you may be interested in